Dáil Éireann Debate, Tuesday - 3 November 2015
702. Deputy Sean Fleming asked the Minister for Health the up-to-date position regarding the approval of the drug fampridine, Fampyra, for persons who suffer from multiple sclerosis; and if he will make a statement on the matter. [37593/15]
Amharc ar fhreagraThe Health Service Executive has confirmed that Fampridine (brand name Fampyra®) is being reimbursed under the Long Term Illness Scheme from 1st October 2015.
Reimbursement will be extended where a demonstration of clinical response (based on objective criteria agreed with clinical experts) is recorded and where that clinical response is shown to persist, based on objective measurement at six-month intervals.
